Inflammaging, a Common Factor in the Development of Sarcopenia and Metabolic-Associated Liver Disease (MAFLD)

Documenti analoghi

• Diagnostics of inflammaging in relation to sarcopenia
  di: Barbara Morawin, et al.
  Pubblicazione: (2023-07-01)
• Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
  di: Kamlesh K. Bhopale, et al.
  Pubblicazione: (2023-10-01)
• Exploring the knowledge and attitudes towards metabolic dysfunction associated fatty liver disease (MAFLD): Validation and correlations of MAFLD-knowledge questionnaire and MAFLD-attitude questionnaire
  di: Samah Al Tawil, et al.
  Pubblicazione: (2024-11-01)
• Lead exposure as a causative factor for metabolic associated fatty liver disease (MAFLD) and a lead exposure related nomogram for MAFLD prevalence
  di: Chenyu Yang, et al.
  Pubblicazione: (2022-10-01)
• Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)
  di: Olga Estévez-Vázquez, et al.
  Pubblicazione: (2021-09-01)